A Fed Skip Cements the Odds for December, Economist Dutta Says
Original Report
“From a risk-management perspective, it probably makes sense to raise rates,” says Neil Dutta, head of US economic research at Renaissance Macro Research, as markets anticipate the Federal Reserve to...
“From a risk-management perspective, it probably makes sense to raise rates,” says Neil Dutta, head of US economic research at Renaissance Macro Research, as markets anticipate the Federal Reserve to hold interest rates steady at this week’s meeting. He speaks on “Bloomberg Surveillance.” (Source: Bloomberg)
Glass House Analysis
Central bank policy decisions made in boardrooms cascade through the economy in ways that touch everyone. A quarter-point rate change might seem abstract, but it determines whether young families can afford homes, whether businesses can afford to hire, and whether retirees see meaningful returns on their savings. The tension between fighting inflation and maintaining employment represents a fundamental tradeoff in economic policy—one that invariably creates winners and losers.
The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.
Enjoyed this analysis?
Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.
No spam. Unsubscribe anytime.
More Stories
Brazil’s Lula Wins ‘Historic Victory’ Against Right-Wing Trump Ally Flávio Bolsonaro
Does the Lula victory in Brazil, despite heavy-handed Trump, Meta and no doubt CIA meddling, signal that Trump is now officially a lame duck?
Anthropic IPO live updates: AI lab lost $80.7 billion in first half of 2026
All the details from Anthropic's IPO prospectus with the Securities and Exchange Commission.
The excitement around Moderna’s cancer vaccine is cooling. Here’s why.
Investors had “incredibly high” expectations around the Phase 3 data for the drugmaker’s experimental cancer treatment.
Apple stock has become an anti-AI trade. Here’s why
As goes Apple, so goes the tech sector. For years, that was the case, but not anymore.